Vanuatu Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Health Times.

Press releases published on November 10, 2026

Nov. 10, 2026

Autolus Therapeutics Presents Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026

Indeterminate GlobeNewswire

Nov. 10, 2026

NextCure Provides Business Update and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 10, 2026

Fortress Biotech Announces an Exclusive License Agreement for FB-607 for the Treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D)

Indeterminate GlobeNewswire

Nov. 10, 2026

Seer Reports Third Quarter 2026 Financial Results and Updates Full Year 2026 Revenue Guidance

Indeterminate GlobeNewswire

Nov. 10, 2026

Adaptive Biotechnologies to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

Nov. 10, 2026

PetMeds® Announces Second Quarter Financial Results

Indeterminate GlobeNewswire

Nov. 10, 2026

Bionano Reports Third Quarter 2026 Results and Provides a Business Update

Indeterminate GlobeNewswire

Nov. 10, 2026

Capricor Therapeutics Reports Third Quarter 2026 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire

Nov. 10, 2026

Metagenomi Therapeutics Announces FDA Clearance of Investigational New Drug Application for MGX-001 and Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 10, 2026

Prime Medicine Announces Proposed $125.0 Million Public Offering of Common Stock

Indeterminate GlobeNewswire

Nov. 10, 2026

Braveheart Bio Reports Third Quarter 2026 Financial Results and Provides Business Update

Indeterminate GlobeNewswire

Nov. 10, 2026

Amneal Named BioSpace 2027 Best Place to Work, Ranking No.1 Among Large Employers

Indeterminate GlobeNewswire

Nov. 10, 2026

Kura Oncology Reports Third Quarter 2026 Financial Results and Corporate Update

Indeterminate GlobeNewswire

Nov. 10, 2026

Stereotaxis Reports 2026 Third Quarter Financial Results & Business Updates

Indeterminate GlobeNewswire

Nov. 10, 2026

Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London

Indeterminate GlobeNewswire

Nov. 10, 2026

Lakefront presenteert op de 2026 Jefferies Global Healthcare Conference in Londen

Indeterminate GlobeNewswire

Nov. 10, 2026

Freenome Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

Nov. 10, 2026

Inhibikase Therapeutics Announces Third Quarter 2026 Financial Results and Highlights Recent Activity

Indeterminate GlobeNewswire

Nov. 10, 2026

Ascendis Pharma to Participate in the Jefferies London Healthcare Conference

Indeterminate GlobeNewswire

Nov. 10, 2026

Stereotaxis Announces Convertible Note Financing of Up To $24 Million

Indeterminate GlobeNewswire